Rosatom Healthcare and CK3 enter into agreement to implement irradiation center

Project relies on the support from Investe São Paulo and will focus on sterilization and pharmaceutical products, cosmetics and other industrial applications

The State Atomic Energy Corporation “Rosatom”, through its subsidiary Rosatom Healthcare (RHC) and the Brazilian company CK3, entered into a Project Development Agreement (PDA) for the joint implementation and operation of an Irradiation Center in Brazil.The document was signed on the Russian side by the general director of RHC, Denis Cherednichenko, and on the Brazilian side, by the director of CK3, Raphael Guiguer.

The Agreement represents an important milestone in the cooperation between the two companies.

Over the course of several months, the parties have extensively studied the market needs, regulations, and technological alternatives, among other key issues to develop the most advanced solutions for the local customers.The project also relied on the support provided by the investment promotion agency of the state government, Investe São Paulo, which is responsible for promoting a dialogue with government entities, providing strategic information and assisting on environmental licensing, taxation and infrastructure matters.

The PDA defines the roadmap for the establishment of a joint venture aimed at offering irradiation services to the Brazilian market.The joint venture will use Russian technologies based on electron and X-ray accelerators for the sterilization of pharmaceutical, cosmetic and healthcare products, among other industrial applications.

On the one hand, the project combines the skills and achievements of Russia in the area of radiation technologies and, on the other hand, the Brazilian experience with the market in the country.  The experiences of RHC and CK3 have the purpose of providing high quality services to customers, following Rosatom’s strategy to increase its market share in Latin America.

“Our joint venture is bringing an attractive alternative to the Brazilian market with an environmentally sound solution,” says Raphael Guiguer, project director of CK3. Unlike other sterilization methods, the electron and X-ray accelerators do not release toxic gases or generate waste.“We are looking forward to the next steps to start offering the services to the customers.”

“We see a huge potential in the Brazilian market of sterilization of medical products by radiation.The use of radiation technologies in the health area in Brazil could significantly improve the safety and quality of goods and services.Hermetically packaged medical products can be effectively sterilized, which reduces the risk of contamination at the production stage.Products treated with the radiation sterilization method will also increase the export potential of Brazilian companies engaged in the production of medical products,” said D. Cherednichenko.

“We have been studying the irradiation market for some time and, despite being relevant in the world, it has little investment in our country.The potential of this sector led us to the decision to invest to diversify our portfolio,” said Rodrigo Cherkezian, director of investor relations at CK3.

“We strongly believe that, after many negotiations, we have found the right partner, because Rosatom has advanced technologies in this field, while having a recognized international presence.The complementary competencies of this union allow us to have a strategy to aggressively enter this market,” adds Cherkezian.

 About the companies

 JSC Rusatom Healthcare was created by the subsidiary of the State Corporation “ROSATOM” - the company JSC “ATOMENERGOPROM” for the development and production of radionuclide equipment and products for nuclear medicine and medical radiology, as well as industrial equipment and sterilization solutions for the processing of different types of products with ionizing radiation based on electron beam and gamma ray installations.

 CK3 is a Brazilian consulting and holding firm, with experience in the development of projects in several sectors, focusing on infrastructure and international negotiations.The company is part of the Cherkezian group, founded in the 1970s. Its parent companies have activities in the real estate development and retail sectors.

• Tweetar